Is Encompass Health Corp (NYSE: EHC) Still On The Rise?

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Yahoo Finance discussed the stock recently as it posted Encompass Health Corp. Named One of the World’s Most Admired Companies in 2024 by Fortune.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Stocks Info

This NYSE-listed company operates within the Medical Care Facilities industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $72.19 and fluctuated between $72.55 as its day high and $71.79 as its day low. The current market capitalization of Encompass Health Corp is $7.24B. A total of 0.5 million shares were traded on the day, compared to an average of 556.14K shares.

Insider Activity

Insider trades can also provide insight into a stock’s future direction. During the recent three months, EHC has seen 1 BUY and 1 SELL insider trades, representing the acquisition of 16,623 and the disposition of 11,215 shares. Over the last 12 months, there were 61 BUYs and 22 SELLs from insiders. Insiders purchased 276,752 shares during that period but sold 77,142.

In the most recent transaction, COLTHARP DOUGLAS E sold 11,215 shares of EHC for 63.39 per share on Nov 13. After the transaction, the EVP & Chief Financial Officer now owns 116,293 company shares. In a previous transaction on Aug 17, Charbonneau Elissa Joy sold 8,294 shares at 69.58 per share. EHC shares that Chief Medical Officer owns now total 23,081.

Among the insiders who sold shares, Tarr Mark J disposed of 25,330 shares on Aug 16 at a per-share price of $71.06. This resulted in the President & CEO holding 497,405 shares of EHC after the transaction. In another insider transaction, COLTHARP DOUGLAS E sold 17,895 shares at $60.78 per share on Feb 10. Company shares held by the EVP & Chief Financial Officer now total 53,097.

Dividend

The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends. Encompass Health Corp pays an annual dividend of $0.60, resulting in a dividend yield of 0.83%, and it has a price to earnings (P/E) ratio of 20.65. EHC’s most recent ex-dividend date was 12/29/2023 when it declared a $0.15 quarterly dividend that was paid in cash on 1/16/2024. Previously, the company paid the dividend on 10/16/2023 with an ex-dividend date of 9/29/2023. The EHC stock dividend was $0.15 per share in cash.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for EHC in the last 3 months, the mean price target is $81.44 with high estimates of $85.00 and low estimates of $77.00. In terms of 52-week highs and lows, EHC has a high of $73.38 and a low of $51.15.

As of this writing, EHC has an earnings estimate of $0.82 per share for the current quarter. EPS was calculated based on a consensus of 10 estimates, with a high estimate of $0.87 per share and a lower estimate of $0.76. The company reported an EPS of $0.95 in the last quarter, which was 28.40% higher than expectations of $0.74.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. EHC’s latest balance sheet shows that the firm has $49.40M in Cash & Short Term Investments as of fiscal 2021. There were $3.48B in debt and $748.80M in liabilities at the time. Its Book Value Per Share was $15.57, while its Total Shareholder’s Equity was $2.40B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EHC is Buy with a score of 4.70.

Most Popular

Related Posts